Victory Capital Management Inc Immunity Bio, Inc. Transaction History
Victory Capital Management Inc
- $92 Billion
- Q1 2025
A detailed history of Victory Capital Management Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 10,707 shares of IBRX stock, worth $31,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,707
Previous 19,768
45.84%
Holding current value
$31,050
Previous $50,000
36.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IBRX
# of Institutions
239Shares Held
79.9MCall Options Held
1.08MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$33.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$12.4 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$9.99 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.16B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...